# Bovine Fibrinogen (Bos taurus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bovine-fibrinogen
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Protein
**Also Known As:** Bos taurus fibrinogen, Bovine plasma fibrinogen, Cattle fibrinogen, BFG, Factor I bovine, Bovine coagulation factor I, Cattle plasma protein

## Overview

Bovine fibrinogen is a blood-derived glycoprotein from Bos taurus that serves as the primary substrate for thrombin-mediated clot formation, converting into insoluble fibrin polymers to achieve hemostasis. Its clinical application centers on surgical hemostatic agents, particularly fibrinogen-collagen fleece composites used in neurosurgery and wound closure procedures.

## Health Benefits

• Effective hemostasis in neurosurgical procedures when used as fibrinogen-based collagen fleece (retrospective study, n=288)
• Potential wound healing support through fibrin clot formation (preclinical evidence only)
• May interact with iron homeostasis through heme-binding properties (in-vitro studies)
• Enhanced clot mechanics in experimental models (laboratory evidence)
• Biocompatibility in surgical settings as topical biomaterial (limited clinical data)

## Mechanism of Action

Bovine fibrinogen is cleaved by the serine protease thrombin at fibrinopeptide A and B sites on the Aα and Bβ chains, generating fibrin monomers that self-polymerize into a cross-linked gel stabilized by Factor XIIIa-mediated ε-(γ-glutamyl)lysine isopeptide bonds. The resulting fibrin matrix activates αvβ3 and α5β1 integrins on platelets and fibroblasts, facilitating platelet aggregation and initiating wound remodeling. Additionally, bovine fibrinogen contains heme-binding domains capable of interacting with iron-containing molecules in vitro, potentially modulating local iron homeostasis, though this pathway remains uncharacterized in vivo.

## Clinical Summary

A retrospective study of 288 neurosurgical patients demonstrated effective intraoperative hemostasis using fibrinogen-based collagen fleece (TachoComb), with no major adverse hemostatic outcomes reported, though the lack of a randomized control group limits causal inference. Preclinical models suggest fibrin clot scaffolds accelerate wound re-epithelialization and fibroblast migration, but no peer-reviewed human RCTs specifically isolating bovine fibrinogen as a supplement for wound healing have been published. In-vitro data indicate heme-iron binding activity at physiological pH, yet no clinical trials have quantified effects on systemic iron parameters or hemoglobin levels in humans. Overall, the evidence base is strongest for topical surgical hemostatic use and remains preliminary or absent for oral supplementation, wound care, or iron [metabolism](/ingredients/condition/weight-management) endpoints.

## Nutritional Profile

Bovine Fibrinogen (Bos taurus) is a high-molecular-weight glycoprotein (MW ~340 kDa) composed predominantly of protein (~96-98% by dry weight), with trace carbohydrate moieties (~3-4% by weight as N-linked oligosaccharide chains including sialic acid, galactose, mannose, and N-acetylglucosamine). Amino acid composition is rich in glutamic acid/glutamine (~11%), aspartic acid/asparagine (~9%), leucine (~8%), lysine (~7%), and glycine (~6%), with a full complement of essential amino acids present. Contains three disulfide-bonded polypeptide chain pairs (Aα, Bβ, Gγ). Iron-binding capacity is attributed to heme-associated porphyrin interactions rather than intrinsic iron content; trace iron may be present at <0.1 mg/g. Calcium is functionally relevant as a cofactor for Factor XIII-mediated cross-linking, present at approximately 2-4 calcium-binding sites per molecule. No dietary fiber, no lipids in purified form, and negligible carbohydrate caloric contribution. Bioavailability as a dietary protein is limited in its fibrinogen form due to large molecular size and structural complexity; proteolytic [digestion](/ingredients/condition/gut-health) yields bioavailable amino acid fragments. As a pharmaceutical/surgical hemostatic agent, systemic absorption of fibrin degradation products (FDPs) occurs post-clot lysis via plasmin activity. Zinc is present in trace amounts (<0.05 mg/g) associated with structural domains. No significant vitamin content detected in purified fibrinogen preparations.

## Dosage & Preparation

No clinically studied dosage ranges exist for bovine fibrinogen as an oral supplement. In biomaterial applications, it is used topically in fixed preparations without standardized dosing. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bovine fibrinogen carries a risk of hypersensitivity and anaphylactic reactions due to its xenogeneic (bovine) protein origin, and individuals with known bovine protein allergies should avoid all formulations. As a blood-derived product, theoretical risk of prion transmission (bovine spongiform encephalopathy) exists, although modern manufacturing employs viral inactivation and sourcing controls to minimize this risk. Concomitant use with anticoagulants such as heparin, warfarin, or direct oral anticoagulants (DOACs like rivaroxaban or apixaban) may counteract fibrinogen-driven clot formation, and concurrent thrombolytic agents (e.g., tissue plasminogen activator) represent a direct pharmacological antagonism. Safety in pregnancy, lactation, and pediatric populations has not been established in controlled clinical trials, and use in these groups should only occur under direct medical supervision.

## Scientific Research

Clinical evidence for bovine fibrinogen as a supplement is notably absent. One retrospective study (n=288) evaluated fibrinogen-based collagen fleece for dural sealing in neurosurgery (PMID: 11956939), but no randomized controlled trials or meta-analyses exist for supplemental use. Current research focuses primarily on preclinical wound models and biomaterial applications.

## Historical & Cultural Context

No evidence of bovine fibrinogen in traditional medicine systems was found. It is a modern biomaterial developed for 20th-21st century scientific applications in coagulation research and tissue engineering, without historical precedents in Ayurveda, TCM, or other traditional practices.

## Synergistic Combinations

Vitamin K, Calcium, Vitamin C, Zinc, Collagen peptides

## Frequently Asked Questions

### What is bovine fibrinogen used for in surgery?

Bovine fibrinogen is used primarily as a hemostatic agent in surgical settings, most notably in fibrinogen-collagen fleece products like TachoComb applied during neurosurgery. A retrospective study of 288 patients confirmed effective intraoperative bleeding control when applied directly to tissue surfaces, where thrombin converts fibrinogen into a fibrin clot within seconds of contact.

### Is bovine fibrinogen safe for people with beef or dairy allergies?

Bovine fibrinogen is derived from Bos taurus blood and is a recognized xenogeneic protein allergen, meaning individuals with bovine protein hypersensitivity face a genuine risk of allergic reactions ranging from localized inflammation to systemic anaphylaxis. People with diagnosed beef protein or bovine-derived product allergies should avoid bovine fibrinogen formulations entirely and consult an allergist or physician before exposure.

### Can bovine fibrinogen interact with blood thinners like warfarin or aspirin?

Yes, bovine fibrinogen can pharmacologically oppose the effects of anticoagulants such as warfarin, heparin, and direct oral anticoagulants (rivaroxaban, apixaban, dabigatran) because it actively promotes fibrin clot formation downstream of these drugs' targets. While topical surgical use is controlled, any systemic exposure combined with antiplatelet agents like aspirin or clopidogrel warrants clinical monitoring, as the net effect on coagulation balance is unpredictable without laboratory assessment.

### Does bovine fibrinogen help with wound healing?

Preclinical evidence suggests that fibrin matrices derived from bovine fibrinogen create scaffolds that facilitate fibroblast migration, angiogenesis, and re-epithelialization at wound sites, primarily through integrin-mediated signaling via αvβ3 and α5β1 receptors. However, no human randomized controlled trials have specifically tested bovine fibrinogen as a standalone wound-healing supplement, so clinical recommendations cannot yet be made beyond its established surgical hemostatic role.

### What is the difference between bovine fibrinogen and human fibrinogen?

Bovine and human fibrinogen share the same trimeric domain structure (Aα, Bβ, and γ chains) and both undergo thrombin-mediated cleavage to form fibrin, but they differ in amino acid sequence homology (approximately 70–75% identity) and glycosylation patterns, which affects immunogenicity. Because bovine fibrinogen is a foreign protein, it carries a higher risk of antibody formation and allergic reactions compared to human-derived or recombinant human fibrinogen products used in clinical transfusion medicine.

### What is the difference between bovine fibrinogen supplements and fibrin sealants used in surgery?

Bovine fibrinogen supplements are oral or topical formulations intended for systemic circulation and general hemostatic support, while fibrin sealants (like fibrinogen-based collagen fleece) are applied directly to surgical sites for localized clotting. Fibrin sealants undergo activation at the point of use through thrombin, whereas oral supplements must be processed through the digestive system and liver before exerting systemic effects. The surgical products are medical devices with defined clinical protocols, whereas dietary supplements have less standardized clinical evidence for oral administration.

### Is bovine fibrinogen safe to use during pregnancy or while breastfeeding?

There is insufficient clinical evidence to establish safety for bovine fibrinogen use during pregnancy or breastfeeding, and it should be avoided without explicit medical clearance. Fibrinogen affects blood coagulation pathways, which undergo significant physiological changes during pregnancy, creating potential risks for both mother and fetus. Pregnant or lactating individuals should consult their healthcare provider before considering any fibrinogen-containing supplement.

### How strong is the clinical evidence supporting bovine fibrinogen for oral supplementation versus surgical applications?

Clinical evidence for bovine fibrinogen is strongest for surgical hemostasis, with retrospective studies (n=288) demonstrating effectiveness when applied directly as fibrinogen-based collagen fleece in neurosurgical procedures. Evidence for oral supplementation and wound healing is limited to preclinical and in-vitro studies, lacking large-scale human clinical trials to confirm efficacy or optimal dosing. Most robust data exists for localized surgical use rather than systemic supplement applications.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*